Protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in SH-SY5Y cells

Full treatment of the second most common neurodegenerative disorder, Parkinson’s disease (PD), is still considered an unmet need. As the psychostimulants, amphetamine (AMPH) and methylphenidate (MPH), were shown to be neuroprotective against stroke and other neuronal injury diseases, this study aime...

Full description

Bibliographic Details
Published in:Current Research in Toxicology
Main Authors: Patrícia Carneiro, Mariana Ferreira, Vera Marisa Costa, Félix Carvalho, João Paulo Capela
Format: Article
Language:English
Published: Elsevier 2024-01-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666027X24000185
_version_ 1850098051434151936
author Patrícia Carneiro
Mariana Ferreira
Vera Marisa Costa
Félix Carvalho
João Paulo Capela
author_facet Patrícia Carneiro
Mariana Ferreira
Vera Marisa Costa
Félix Carvalho
João Paulo Capela
author_sort Patrícia Carneiro
collection DOAJ
container_title Current Research in Toxicology
description Full treatment of the second most common neurodegenerative disorder, Parkinson’s disease (PD), is still considered an unmet need. As the psychostimulants, amphetamine (AMPH) and methylphenidate (MPH), were shown to be neuroprotective against stroke and other neuronal injury diseases, this study aimed to evaluate their neuroprotective potential against two dopaminergic neurotoxicants, 6-hydroxydopamine (6-OHDA) and paraquat (PQ), in differentiated human dopaminergic SH-SY5Y cells.Neither cytotoxicity nor mitochondrial membrane potential changes were seen following a 24-hour exposure to either therapeutic concentration of AMPH or MPH (0.001–10 μM). On the other hand, a 24-hour exposure to 6-OHDA (31.25–500 μM) or PQ (100–5000 μM) induced concentration-dependent mitochondrial dysfunction, assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, and lysosomal damage, evaluated by the neutral red uptake assay. The lethal concentrations 25 and 50 retrieved from the concentration-toxicity curves in the MTT assay were 99.9 µM and 133.6 µM for 6-OHDA, or 422 µM and 585.8 µM for PQ. Both toxicants caused mitochondrial membrane potential depolarization, but only 6-OHDA increased reactive oxygen species (ROS). Most importantly, PQ-induced toxicity was partially prevented by 1 μM of AMPH or MPH. Nonetheless, neither AMPH nor MPH could prevent 6-OHDA toxicity in this experimental model.According to these findings, AMPH and MPH may provide some neuroprotection against PQ-induced neurotoxicity, but further investigation is required to determine the exact mechanism underlying this protection.
format Article
id doaj-art-eec0c9870e994e46ae92e46dc3d8795e
institution Directory of Open Access Journals
issn 2666-027X
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
spelling doaj-art-eec0c9870e994e46ae92e46dc3d8795e2025-08-20T00:06:02ZengElsevierCurrent Research in Toxicology2666-027X2024-01-01610016510.1016/j.crtox.2024.100165Protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in SH-SY5Y cellsPatrícia Carneiro0Mariana Ferreira1Vera Marisa Costa2Félix Carvalho3João Paulo Capela4Associate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO – Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050‐313 Porto, PortugalAssociate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO – Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050‐313 Porto, PortugalAssociate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO – Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050‐313 Porto, PortugalAssociate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO – Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050‐313 Porto, PortugalAssociate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal; UCIBIO – Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050‐313 Porto, Portugal; FP3ID, Faculdade de Ciências da Saúde, Universidade Fernando Pessoa, Rua Carlos da Maia 296, 4200-150 Porto, Portugal; Corresponding author.Full treatment of the second most common neurodegenerative disorder, Parkinson’s disease (PD), is still considered an unmet need. As the psychostimulants, amphetamine (AMPH) and methylphenidate (MPH), were shown to be neuroprotective against stroke and other neuronal injury diseases, this study aimed to evaluate their neuroprotective potential against two dopaminergic neurotoxicants, 6-hydroxydopamine (6-OHDA) and paraquat (PQ), in differentiated human dopaminergic SH-SY5Y cells.Neither cytotoxicity nor mitochondrial membrane potential changes were seen following a 24-hour exposure to either therapeutic concentration of AMPH or MPH (0.001–10 μM). On the other hand, a 24-hour exposure to 6-OHDA (31.25–500 μM) or PQ (100–5000 μM) induced concentration-dependent mitochondrial dysfunction, assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, and lysosomal damage, evaluated by the neutral red uptake assay. The lethal concentrations 25 and 50 retrieved from the concentration-toxicity curves in the MTT assay were 99.9 µM and 133.6 µM for 6-OHDA, or 422 µM and 585.8 µM for PQ. Both toxicants caused mitochondrial membrane potential depolarization, but only 6-OHDA increased reactive oxygen species (ROS). Most importantly, PQ-induced toxicity was partially prevented by 1 μM of AMPH or MPH. Nonetheless, neither AMPH nor MPH could prevent 6-OHDA toxicity in this experimental model.According to these findings, AMPH and MPH may provide some neuroprotection against PQ-induced neurotoxicity, but further investigation is required to determine the exact mechanism underlying this protection.http://www.sciencedirect.com/science/article/pii/S2666027X24000185AmphetamineMethylphenidate6-HydroxydopamineParaquatSH-SY5Y cellsNeuroprotection
spellingShingle Patrícia Carneiro
Mariana Ferreira
Vera Marisa Costa
Félix Carvalho
João Paulo Capela
Protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in SH-SY5Y cells
Amphetamine
Methylphenidate
6-Hydroxydopamine
Paraquat
SH-SY5Y cells
Neuroprotection
title Protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in SH-SY5Y cells
title_full Protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in SH-SY5Y cells
title_fullStr Protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in SH-SY5Y cells
title_full_unstemmed Protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in SH-SY5Y cells
title_short Protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in SH-SY5Y cells
title_sort protective effects of amphetamine and methylphenidate against dopaminergic neurotoxicants in sh sy5y cells
topic Amphetamine
Methylphenidate
6-Hydroxydopamine
Paraquat
SH-SY5Y cells
Neuroprotection
url http://www.sciencedirect.com/science/article/pii/S2666027X24000185
work_keys_str_mv AT patriciacarneiro protectiveeffectsofamphetamineandmethylphenidateagainstdopaminergicneurotoxicantsinshsy5ycells
AT marianaferreira protectiveeffectsofamphetamineandmethylphenidateagainstdopaminergicneurotoxicantsinshsy5ycells
AT veramarisacosta protectiveeffectsofamphetamineandmethylphenidateagainstdopaminergicneurotoxicantsinshsy5ycells
AT felixcarvalho protectiveeffectsofamphetamineandmethylphenidateagainstdopaminergicneurotoxicantsinshsy5ycells
AT joaopaulocapela protectiveeffectsofamphetamineandmethylphenidateagainstdopaminergicneurotoxicantsinshsy5ycells